Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.061 USD | -0.81% | -0.81% | -59.31% |
Feb. 26 | Tanke Biosciences Corp Appoints Kenneth Marks to the Board of Directors | CI |
Feb. 08 | Tanke Biosciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 | CI |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 1.35M |
---|---|---|---|---|---|
Net income 2021 | - | Net income 2022 | - | EV / Sales 2021 | - |
Net cash position 2021 | 39.68K | Net Debt 2022 | 45.73K | EV / Sales 2022 | - |
P/E ratio 2021 |
-21.5
x | P/E ratio 2022 |
-12.9
x | Employees | 130 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 23.04% |
1 day | -0.81% | ||
1 week | -0.81% | ||
Current month | -20.37% | ||
1 month | -20.37% | ||
3 months | -39.00% | ||
6 months | -39.00% | ||
Current year | -59.31% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Mills
CEO | Chief Executive Officer | - | 21-10-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Mills
CEO | Chief Executive Officer | - | 21-10-21 |
1st Jan change | Capi. | |
---|---|---|
-59.31% | 1.29M | |
+11.04% | 11.48B | |
-4.29% | 5.8B | |
-1.49% | 5.05B | |
+1.02% | 4.23B | |
-21.31% | 2.67B | |
+1.63% | 1.77B | |
-22.67% | 1.13B | |
-20.67% | 933M | |
-16.12% | 886M |
- Stock Market
- Equities
- TNBI Stock